Comparing the Accuracy of Different Blood Glucose Monitoring Systems (CGM and FGM)
Comparing the Accuracy of Different Blood Glucose Monitoring Systems (CGM and FGM) With Venous Blood Glucose
Sponsor: Nanjing First Hospital, Nanjing Medical University
Listed as NCT04099745, this NA trial focuses on Type 2 Diabetes and remains ongoing. Sponsored by Nanjing First Hospital, Nanjing Medical University, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2019 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Nanjing First Hospital, Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.